Safety of Arthritis Drugs, Day 2, Part 1
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Dru… read more
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close
People in this video
-
Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
More Videos From
Safety of Arthritis Drugs, Day 2,
More VideosRelated Video
-
Overdosed America
Dr. John Abramson talked about his book Overdosed America: The Broken Promise of American Medicine, published by HarperC…
-
Food and Drug Safety
Food and Drug Administration Acting Commissioner Lester Crawford talked about consumer safety, regulatory practices at t…
-
Food and Drug Administration Issues
The Food and Drug Administration’s Acting Commissioner Lester Crawford talked about the Food and Drug Administration’s e…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional ove…